Location History:
- Kamakura, JP (2016)
- Kanagawa, JP (2021)
Company Filing History:
Years Active: 2016-2021
Title: Kana Suzuki: Pioneering Cancer Detection Innovations
Introduction
Kana Suzuki is a notable inventor based in Kanagawa, Japan, recognized for his significant contributions to the field of cancer detection. With two patents under his name, his research focuses on innovative methodologies that leverage the capabilities of polypeptides and antibodies, providing breakthroughs in cancer diagnostics.
Latest Patents
Suzuki's latest patents include a revolutionary method for detecting cancer using CAPRIN-1 as a marker. This invention proposes a technique that involves measuring the expression of a polypeptide, which has a reactivity of binding to an antibody against a CAPRIN-1 protein, through an antigen-antibody reaction in samples from living organisms. The reagent for cancer detection developed in this patent includes the CAPRIN-1 protein or its fragments, along with corresponding antibodies or polynucleotides.
Another significant patent is a method for detecting cancers based on the expression of designated polypeptides. This method utilizes the SEREX technique, whereby polypeptides isolated from a cDNA library derived from canine testis are explored for their ability to bind antibodies present in the serum of cancer-bearing dogs. By measuring these antibody levels or the antigen protein itself, the method enables the detection of cancers in living bodies.
Career Highlights
Kana Suzuki works at Toray Industries, Inc., where he collaborates with fellow researcher Fumiyoshi Okano. Together, they strive to advance cancer detection methods, emphasizing the importance of innovative technologies in the medical field. Suzuki's career is marked by a commitment to improving diagnostic techniques that can lead to earlier detection and better treatment outcomes for cancer patients.
Collaborations
Collaboration is key to Suzuki's innovative work. Partnering with Fumiyoshi Okano enhances his research capabilities, as their combined expertise allows them to explore new dimensions within cancer detection. Their teamwork exemplifies the collaborative spirit essential in research environments, addressing complex problems through shared insights and knowledge.
Conclusion
Kana Suzuki's contributions to cancer detection methodologies highlight the impact of innovation in medicine. With his recent patents, he pushes the boundaries of what is possible, aiming to improve the lives of those affected by cancer. His work at Toray Industries, Inc. and collaboration with Fumiyoshi Okano underscores the vital role of teamwork in driving forward scientific advancements.